Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fibrin sealant final guidance

This article was originally published in The Gray Sheet

Executive Summary

Data from representative surgical procedures can support FDA approval for an indication covering a group of surgical procedures, according to the May 20 final document. Inclusion of the statement comes in response to a comment received by the agency pertaining to a January 1998 draft guidance, "Efficacy Studies to Support Marketing of Fibrin Sealant Products Manufactured for Commercial Use" ("The Gray Sheet" Feb. 16, 1998, I&W-9)
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT011800

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel